The specific magnitude of this effect with retatrutide has not been fully characterised
The treatment group showed significant reductions in body weight (approximately 5% loss) and white adipose tissue mass (35% reduction) compared to control animals, despite no changes in food intake
However, coverage still depends on the specific TRICARE plan, provider network, and whether the treatment is considered medically necessary
Medications, like insulin, are effective when they're injected into the fatty tissue just below the skin
This pattern indicates that AOD-9604 produces minimal additional symptom burden beyond what would be expected in the absence of treatment
Your provider can integrate it with other treatments, like our sports injury care or therapeutic bodywork, to support your healing from all angles